The Life Sciences team advised Lauxera Capital Partners on the intellectual property aspects of its €17 million investment in BioLamina AB.
Founded in January 2020, Lauxera Capital Partners is an independent asset management company based in Paris, France and in San Francisco, California.
BioLamina is a biotechnology company with a scientific base and heritage in matrix biology and cell culture research.
The Goodwin team included Duncan Greenhalgh, Lily Xu, and Pamela Johnson.
For more details, read the press release.